58531-92-3 Usage
General Description
The chemical compound "(amino{[4-(dimethylamino)phenyl]methylidene}carbonohydrazonoyl)selanyl" is a complex organic compound containing carbon, nitrogen, hydrogen, and selenium. It is a carbonylhydrazone derivative with a selenium atom substituent. The compound's chemical structure contains a dimethylamino group, and a phenylmethylidene group, both of which are attached to the carbon and nitrogen atoms. (amino{[4-(dimethylamino)phenyl]methylidene}carbonohydrazonoyl)selanyl may have potential applications in chemical and pharmaceutical industries due to its unique structure and potential medicinal properties. Its properties and potential uses would require further research and analysis.
Check Digit Verification of cas no
The CAS Registry Mumber 58531-92-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,5,3 and 1 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 58531-92:
(7*5)+(6*8)+(5*5)+(4*3)+(3*1)+(2*9)+(1*2)=143
143 % 10 = 3
So 58531-92-3 is a valid CAS Registry Number.
58531-92-3Relevant articles and documents
New approach towards the synthesis of selenosemicarbazones, useful compounds for Chagas' disease
Pizzo, Chiara,Faral-Tello, Paula,Yaluff, Gloria,Serna, Elva,Torres, Susana,Vera, Ninfa,Saiz, Cecilia,Robello, Carlos,Mahler, Graciela
, p. 107 - 113 (2016/01/15)
Herein, we describe a new approach towards the synthesis of selenosemicarbazones. The reaction involves an O-Se exchange of semicarbazones using Ishihara reagent. Eleven selenosemicarbazones were prepared using this methodology, with low to moderate yields. Among the prepared compounds the m-bromo phenyl methyl derivative 1b was selected to be evaluated in vivo, in a murine model of acute Chagas' disease. Compound 1b 10 mg/kg bw/day reduced 50% of parasitaemia profile compared with the control group, but was less effective than Benznidazole (50 mg/kg bw/day reduced 90%) and toxic. These studies are important to guide future Chagas drug design.
